META vs REGN · P/E 29, rev $200.97B vs P/E 14, rev $14.34B
Meta Platforms Inc. (META) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
META currently screens at market cap $1.64T and trailing P/E 28.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the META and REGN stock pages for the full models.
Not investment advice.